Literature DB >> 15530573

The use of Caenorhabditis elegans in molecular neuropharmacology.

Jill C Bettinger1, Lucinda Carnell, Andrew G Davies, Steven L McIntire.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15530573     DOI： 10.1016/S0074-7742(04)62007-1

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN： 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  5 in total

1.  Differences of acute versus chronic ethanol exposure on anxiety-like behavioral responses in zebrafish.

Authors:  Priya Mathur; Su Guo
Journal:  Behav Brain Res       Date:  2011-01-19       Impact factor: 3.332

2.  Behavioral effects of clozapine: involvement of trace amine pathways in C. elegans and M. musculus.

Authors:  Rakesh Karmacharya; Spencer K Lynn; Sarah Demarco; Angelica Ortiz; Xin Wang; Miriam Y Lundy; Zhihua Xie; Bruce M Cohen; Gregory M Miller; Edgar A Buttner
Journal:  Brain Res       Date:  2011-04-09       Impact factor: 3.252

Review 3.  Caenorhabditis elegans as a Biological Model for Multilevel Biomarker Analysis in Environmental Toxicology and Risk Assessment.

Authors:  Jinhee Choi
Journal:  Toxicol Res       Date:  2008-12-01

4.  Increased dopaminergic neurotransmission results in ethanol dependent sedative behaviors in Caenorhabditis elegans.

Authors:  Pratima Pandey; Anuradha Singh; Harjot Kaur; Anindya Ghosh-Roy; Kavita Babu
Journal:  PLoS Genet       Date:  2021-02-01       Impact factor: 5.917

5.  Clozapine interaction with phosphatidyl inositol 3-kinase (PI3K)/insulin-signaling pathway in Caenorhabditis elegans.

Authors:  Rakesh Karmacharya; Gregory R Sliwoski; Miriam Y Lundy; Raymond F Suckow; Bruce M Cohen; Edgar A Buttner
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.